Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 24

1.

Humanized mouse models reveal an immunologic classification of idiopathic CD4 lymphocytopenia subtypes.

Perez-Diez A, Liu X, Sheikh V, Roby G, Stroncek DF, Sereti I.

JCI Insight. 2019 Jul 25;4(14). pii: 127802. doi: 10.1172/jci.insight.127802. eCollection 2019 Jul 25.

2.

Corrigendum: Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 Jul 4;10:1552. doi: 10.3389/fimmu.2019.01552. eCollection 2019.

3.

Paradoxical CD4 Lymphopenia in Autoimmune Lymphoproliferative Syndrome (ALPS).

Lisco A, Wong CS, Price S, Ye P, Niemela J, Anderson M, Richards E, Manion M, Mystakelis H, Similuk M, Lo B, Stoddard J, Rosenzweig S, Vanpouille C, Rupert A, Maric I, Perez-Diez A, Parenti D, Burbelo PD, Rao VK, Sereti I.

Front Immunol. 2019 May 29;10:1193. doi: 10.3389/fimmu.2019.01193. eCollection 2019. Erratum in: Front Immunol. 2019 Jul 04;10:1552.

4.

Identification of rare HIV-1-infected patients with extreme CD4+ T cell decline despite ART-mediated viral suppression.

Lisco A, Wong CS, Lage SL, Levy I, Brophy J, Lennox J, Manion M, Anderson MV, Mejia Y, Grivas C, Mystakelis H, Burbelo PD, Perez-Diez A, Rupert A, Martens CA, Anzick SL, Morse C, Chan S, Deleage C, Sereti I.

JCI Insight. 2019 Apr 18;4(8). pii: 127113. doi: 10.1172/jci.insight.127113. eCollection 2019 Apr 18.

5.

Administration of interleukin-7 increases CD4 T cells in idiopathic CD4 lymphocytopenia.

Sheikh V, Porter BO, DerSimonian R, Kovacs SB, Thompson WL, Perez-Diez A, Freeman AF, Roby G, Mican J, Pau A, Rupert A, Adelsberger J, Higgins J, Bourgeois JS Jr, Jensen SM, Morcock DR, Burbelo PD, Osnos L, Maric I, Natarajan V, Croughs T, Yao MD, Estes JD, Sereti I.

Blood. 2016 Feb 25;127(8):977-88. doi: 10.1182/blood-2015-05-645077. Epub 2015 Dec 16.

6.

T-Cell Depletion in the Colonic Mucosa of Patients With Idiopathic CD4+ Lymphopenia.

Kovacs SB, Sheikh V, Thompson WL, Morcock DR, Perez-Diez A, Yao MD, Rupert AW, Utay NS, Roby G, Freeman AF, Estes JD, Sereti I.

J Infect Dis. 2015 Nov 15;212(10):1579-87. doi: 10.1093/infdis/jiv282. Epub 2015 May 20.

7.

Notch signaling regulates antigen sensitivity of naive CD4+ T cells by tuning co-stimulation.

Laky K, Evans S, Perez-Diez A, Fowlkes BJ.

Immunity. 2015 Jan 20;42(1):80-94. doi: 10.1016/j.immuni.2014.12.027. Epub 2015 Jan 1.

8.

Resident peritoneal NK cells.

Gonzaga R, Matzinger P, Perez-Diez A.

J Immunol. 2011 Dec 15;187(12):6235-42. doi: 10.4049/jimmunol.1101540. Epub 2011 Nov 11.

9.

The ability of natural tolerance to be applied to allogeneic tissue: determinants and limits.

Chan WF, Perez-Diez A, Razavy H, Anderson CC.

Biol Direct. 2007 Apr 16;2:10.

10.

The JAM Test and its daughter P-JAM: simple tests of DNA fragmentation to measure cell death and stasis.

Usharauli D, Perez-Diez A, Matzinger P.

Nat Protoc. 2006;1(2):672-82.

PMID:
17406295
11.

CD4 cells can be more efficient at tumor rejection than CD8 cells.

Perez-Diez A, Joncker NT, Choi K, Chan WF, Anderson CC, Lantz O, Matzinger P.

Blood. 2007 Jun 15;109(12):5346-54. Epub 2007 Feb 27.

12.

Microarrays for cancer diagnosis and classification.

Perez-Diez A, Morgun A, Shulzhenko N.

Adv Exp Med Biol. 2007;593:74-85. Review.

PMID:
17265718
13.

Molecular profiling improves diagnoses of rejection and infection in transplanted organs.

Morgun A, Shulzhenko N, Perez-Diez A, Diniz RV, Sanson GF, Almeida DR, Matzinger P, Gerbase-DeLima M.

Circ Res. 2006 Jun 23;98(12):e74-83.

PMID:
16794196
14.

Prospective molecular profiling of melanoma metastases suggests classifiers of immune responsiveness.

Wang E, Miller LD, Ohnmacht GA, Mocellin S, Perez-Diez A, Petersen D, Zhao Y, Simon R, Powell JI, Asaki E, Alexander HR, Duray PH, Herlyn M, Restifo NP, Liu ET, Rosenberg SA, Marincola FM.

Cancer Res. 2002 Jul 1;62(13):3581-6.

15.

Immunotherapy against antigenic tumors: a game with a lot of players.

Pérez-Díez A, Marincola FM.

Cell Mol Life Sci. 2002 Feb;59(2):230-40. Review.

PMID:
11915941
16.

Intensity of the vaccine-elicited immune response determines tumor clearance.

Perez-Diez A, Spiess PJ, Restifo NP, Matzinger P, Marincola FM.

J Immunol. 2002 Jan 1;168(1):338-47.

17.

Genetic heterogeneity in the toxicity to systemic adenoviral gene transfer of interleukin-12.

Mazzolini G, Narvaiza I, Pérez-Diez A, Rodriguez-Calvillo M, Qian C, Sangro B, Ruiz J, Prieto J, Melero I.

Gene Ther. 2001 Feb;8(4):259-67.

18.

Kinetics of TCR use in response to repeated epitope-specific immunization.

Monsurrò V, Nielsen MB, Perez-Diez A, Dudley ME, Wang E, Rosenberg SA, Marincola FM.

J Immunol. 2001 May 1;166(9):5817-25.

19.

Status of activation of circulating vaccine-elicited CD8+ T cells.

Nielsen MB, Monsurro V, Migueles SA, Wang E, Perez-Diez A, Lee KH, Kammula U, Rosenberg SA, Marincola FM.

J Immunol. 2000 Aug 15;165(4):2287-96.

20.

Immunoregulating properties of peptides related to tumor rejection antigens: effect on human monocytes and natural killer cells.

Pérez-Díez A, Martínez-Crespo A, Pérez-Mediavilla LA, Santiago E, López-Moratalla N.

J Immunother. 2000 Mar-Apr;23(2):215-24.

PMID:
10746548
21.

[Benzodiazepine prescription at a health center: prevalence, its use and user characteristics].

Escrivá Ferrairó R, Pérez Díez A, Lumbreras García C, Molina París J, Sanz Cuesta T, Corral Sánchez MA.

Aten Primaria. 2000 Feb 15;25(2):107-10. Spanish.

22.

Myeloablative chemotherapy with autologous peripheral blood stem cell transplantation for metastatic breast cancer: immunologic consequences affecting clinical outcome.

Chakraborty N, Bilgrami S, Maness L, Guo C, Perez-Diez A, Mukherji B, Tutschka P.

Bone Marrow Transplant. 1999 Oct;24(8):837-43.

23.

Generation of CD8+ and CD4+ T-cell response to dendritic cells genetically engineered to express the MART-1/Melan-A gene.

Pérez-Díez A, Butterfield LH, Li L, Chakraborty NG, Economou JS, Mukherji B.

Cancer Res. 1998 Dec 1;58(23):5305-9.

24.

Immunomodulation induced by synthetic peptides derived from tumor-rejection antigens.

Perez-Diez A, Martinez-Crespo A, Perez-Mediavilla LA.

Int J Dev Biol. 1996;Suppl 1:311S. No abstract available.

Supplemental Content

Loading ...
Support Center